| Notice of Special Interest (NOSI): Translating Biomaterials-Based Technologies to Commercially Viable Products |
NOT-EB-24-001 |
|
|
| Notice of Removal of Matching Requirement Instructions for RFA-EB-18-003 "HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed)" |
NOT-EB-19-003 |
|
|
| Notice of Reissuance of PAR-16-106 and Change in Due Dates for R21 Applications on the Assessment of Zika Virus (ZIKV) Complications |
NOT-HD-16-036 |
|
|
| Notice of Participation of the NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) |
NOT-EB-18-006 |
|
|
| Notice of Participation of NIBIB in PA-15-034 Administrative Supplements for Research on Sex/Gender Differences |
NOT-EB-15-001 |
|
|
| Notice of Participation of NIBIB in "RFA-NS-22-025 HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)" |
NOT-EB-23-013 |
|
|
| Notice of Participation of NIBIB in "RFA-NS-22-022 HEAL Initiative Advanced Postdoctoral-to-Independent Career Transition Award in PAIN and SUD Research (K99/R00 Independent Clinical Trial Not Allowed)" |
NOT-EB-23-015 |
|
|
| Notice of Participation of Additional NIH Institutes and Centers in PAR-20-153: Science Education Partnership Awards (SEPA) (R25-Clinical Trial Not Allowed) |
NOT-HG-22-006 |
|
|
| Notice of Participation of Additional NIH Institutes and Centers in PAR-20-153: Science Education Partnership Awards (SEPA) (R25-Clinical Trial Not Allowed) |
NOT-HG-22-017 |
|
|
| Notice of NIH/BD2K Participation in the Joint NSF/NIH Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD) |
NOT-EB-16-008 |
|
|
